QR kȏd

PO45 | KHORANA RISK SCORE AND GENOMIC PROFILING FOR PREDICTION OF VENOUS THROMBOEMBOLISM IN OVARIAN CANCER

Introduction. Ovarian cancer carries a high thromboembolic risk, with VTE incidence up to 13.3%. We conducted a retrospective cohort study to assess Khorana Risk Score (KRS) performance and explore mutational differences between patients with ovarian cancer with and without VTE. Aims. To assess the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: Paolo Santini
Format: Artigo
Jezik:Inglês
Izdano: PAGEPress Publications 2026-04-01
Serija:Bleeding, Thrombosis and Vascular Biology
Online pristup:https://www.btvb.org/btvb/article/view/539
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!